Table 5 |
||||||
|
Prognostic significance of factors for overall survival, disease free survival, and distant disease free survival |
||||||
| BM |
HER2 |
HER2F |
Top IIa |
Ki 67 |
p53 |
|
|
|
||||||
| OS |
0.03 |
0.33a |
0.22a |
0.52 |
0.26 |
0.98 |
| DFS |
0.36 |
0.03 |
0.03 |
0.58 |
0.04a |
0.23 |
| DDFS |
0.09 |
0.06a |
0.05a |
0.49 |
0.09a |
0.22 |
|
|
||||||
|
aSignificance in the subgroup of patients without adjuvant therapy (n = 138). BM, bone marrow; DDFS, distant disease free survival; DFS, disease free survival; HER2, human epithelial growth factor receptor 2; HER2F, HER2 FISH, OS, overall survival; Top IIa, topoisomerase IIα. |
||||||
|
Schindlbeck et al. Breast Cancer Research 2005 7:R1174 doi:10.1186/bcr1360 |
||||||
